|Year : 2014 | Volume
| Issue : 4 | Page : 565-569
Young onset colorectal cancer: How does it differ from its older counterpart?
SS Saluja1, JM Manipadam1, PK Mishra1, S Sachdeva2, N Solanki1, H Shah1
1 Department of Gastrointestinal Surgery, GB Pant Hospital, New Delhi, India
2 Department of Gastroenterology, GB Pant Hospital, New Delhi, India
|Date of Web Publication||1-Feb-2016|
P K Mishra
Department of Gastrointestinal Surgery, GB Pant Hospital, New Delhi
Source of Support: None, Conflict of Interest: None
Background: Colorectal cancer in the young has been a debated topic in literature with conflicting reports as to its pattern of occurrence and survival as compared to the older age group. Materials And Methods: Retrospective study to analyze the clinicopathological characteristics, treatment modalities and survival of sporadic young-onset colorectal cancer (YOCR) patients (<40 years) and compare them with the older group (>40 years). Results: Of 172 patients managed, 72 (42%) were in the YOCR group. Among 72 patients, six were excluded because of hereditary syndromes. Incontinence (P = 0.02) and obstruction at time of presentation (P = 0.03) was significantly more common in the YOCR group. Left sided disease was more common in YOCR group (47/66) compared to the older group (65/100), but the difference was not statistically significant (P = 0.45). The proportion of rectal cancers was significantly more in the YOCR group (39/47) compared to the older group (39/65) (P = 0.01). Significant difference in resectability was noted in the left sided (YOCR 26/47 vs. older 49/65 P = 0.04) and the rectal cancers (YOCR 18/39 vs. Older 29/39 P = 0.02). The survival was similar among the two groups. Conclusions: Sporadic colorectal cancers in the young are more advanced and less resectable when compared to older population. Genetic studies are needed to elaborate the reasons for left sided predominance and aggressiveness of sporadic colorectal cancers in the younger subgroups.
Keywords: Anterior resection, colorectal cancer, young onset
|How to cite this article:|
Saluja S S, Manipadam J M, Mishra P K, Sachdeva S, Solanki N, Shah H. Young onset colorectal cancer: How does it differ from its older counterpart?. Indian J Cancer 2014;51:565-9
|How to cite this URL:|
Saluja S S, Manipadam J M, Mishra P K, Sachdeva S, Solanki N, Shah H. Young onset colorectal cancer: How does it differ from its older counterpart?. Indian J Cancer [serial online] 2014 [cited 2020 Aug 5];51:565-9. Available from: http://www.indianjcancer.com/text.asp?2014/51/4/565/175350
| » Introduction|| |
Colorectal cancer in the young is a much debated topic in literature with conflicting reports as to its pattern of occurrence and survival when compared to the older age group. There are reports that talk of these malignancies to be predominantly left sided and to be more advanced with a poorer prognosis.,,,, Simultaneously, there are some reports that suggest young colorectal cancers of being predominantly right sided , and having a better stage-specific survival when compared to the older age group., This is further complicated by the fact that most studies have not excluded patients with ulcerative colitis and hereditary cancer syndromes.,,, The reports of single center studies of the eighties and nineties varied with a wide range showing no consistent pattern. An early report in the eighties showed a similar distribution of the sites of colorectal cancer in the young and the old with a better survival for the young. Minardi et al. stated that colorectal cancer is distributed evenly throughout the colon in young patients though it is diagnosed at a more advanced stage when compared to the elderly. Fairley et al. stated in 2006 that rectal cancers were diagnosed more commonly and proximal cancers less commonly in young patients <50 years compared to adults. O'Connell et al. stated that the 5 year stage specific survival in stage two and four is actually better in the young onset colorectal cancer (YOCR) group when compared with the old. The population-based studies that came in 2000 had different results as far as survival was concerned and they did not place emphasis on the details of the modalities of treatment these patients received.,, Most of the reports are from the west and there are no reports from the Indian subcontinent. Therefore, we took up this study to analyze the patterns of YOCR in the subset of Indian population that attended our tertiary center for the last 10 years and compared them with the older age group colorectal cancer patients who attended our hospital during the same time period.
| » Materials and Methods|| |
All colorectal cancer patients who attended the outpatient department of our surgical unit and received treatment either in the form of surgery, preoperative neoadjuvant therapy, adjuvant therapy or palliative chemotherapy in our hospital from 2003 to 2012 were analyzed retrospectively from a prospectively maintained database.
We divided patients into two groups (a) the YOCR group including patients with age up to 40 years (b) the older group (O), including patients with age more than 40 years. Patients with ulcerative colitis and known hereditary cancer syndromes were excluded from the study in order to estimate the true nature and trends of the sporadic colorectal cancer in the young.
The age wise subgroup analysis was done in young onset group by dividing the young group into up to 20, 21–30 and 31–40 subgroups. Stage-wise analysis was performed according to TNM classification AJCC seventh edition.
Location of the tumor, clinical presentation, histopathology, carcinoembryonic antigen (CEA) levels, stage distribution, resectability and survival were analyzed and compared between the two groups.
Work up and management policy
In our institution, complete work up of patients presenting with colorectal cancer include serum CEA levels, contrast enhanced computed tomography (CECT) scan of abdomen and pelvis and colonoscopy. Magnetic resonance imaging was done in selected patients with rectal cancer. Early stage disease was taken up directly for the operation, and laparoscopic approach was attempted on the discretion of the surgeon. Locally advanced mid and lower rectal disease (t3 and above/nodal disease) were planned for neoadjuvant chemoradiotherapy, followed by operation. This policy of neoadjuvant chemoradiotherapy was followed during the latter half of the period of this study while the patients in the initial half were subjected to the operation followed by adjuvant therapy. Patients with metastatic disease presenting with obstruction underwent a decompression stoma followed by chemoradiotherapy and reassessment. Locally advanced colonic cancer including rectosigmoid tumors underwent resection followed by adjuvant therapy. Metastatic colonic cancer underwent palliative resection, bypass or stoma depending upon the extent of adjacent organ involvement and metastasis followed by chemotherapy.
Our follow up strategy was to review patients postoperatively every 3 months with serial CEA and physical examination, CECT abdomen for patients at high risk of recurrence annually for 3 years, colonoscopy at 1 year that would be repeated at 3 years and then every 5 years.
All the data were enumerated using Microsoft excel 2007 by Microsoft Inc., and Fischer's exact test for categorical variables available at Graphpad Software quickcalcs by Graphpad software Inc. was used for statistical analysis. Log rank test of SPSS 16 software by SPSS Inc was used to compare the survival curves of the young versus old in the various stage subgroups.
| » Results|| |
A total of 172 patients of colorectal malignancy were managed from 2003 to 2011. There were 72 patients in the YOCR cancer group and 100 patients in the older group. Of 72 patients in YOCR group, six patients having predisposing conditions (ulcerative colitis n = 2, familial adenomatous polyposis n = 1, juvenile polyposis coli n = 1, Peutz jegher syndrome n = 1 and neuroendocrine histology n = 1) were excluded.
The incidence of YOCR cancer was 42% among colorectal cancer patients attending our outpatient department in this study. The male: Female ratio was 1.5:1 in the YOCR group while 4:1 in the older group with a statistically significant difference (P = 0.01).
Location of the tumor
The distribution of left and right sided cancers is listed in [Table 1]. In YOCR group 47 (71%) patients were left sided. In a subgroup analysis, eight patients were seen in up to 20 years. All had left sided rectal disease. Among 17 patients in age group 21–30 years, 13 (76%) had left sided rectal cancers. Patients between 30 and 40 years had both right sided (37%) and left sided tumors (63%). In the older group, 35 patients had right sided tumor while 65 were left sided cancers. Thus left sided disease was more common in the younger age group compared to the older group but the difference was not statistically significant (P = 0.45). The difference attained statistical significance among age <30 years (P = 0.03). In YOCR group among 47 left sided tumors, 39 patients had rectal or rectosigmoid tumors while in the older subgroup among 65 left sided tumors, 39 had rectal or rectosigmoid tumors. The difference was statistically significant (P = 0.01).
The median duration before presentation was similar among YOCR (6 months [range 1 month–4 years]) and older group (6 months [range 1 month–3 years)]. Various clinical symptoms included bleeding per rectum, altered bowel habits, anorexia, lump abdomen, obstruction, tenesmus, pain abdomen, incontinence, easy fatigability and incomplete defecation. A comparison of clinical features in the younger group to the older group is shown in [Table 2]. Incontinence (P = 0.02) and obstruction at time of presentation (P = 0.03) was significantly more common in the YOCR group.
|Table 2: Comparison of the symptoms of colorectal cancer in the young with that in the old|
Click here to view
Histopathology and carcinoembryonic antigen level
In the older group out of 100 patients, 15 had mucinous, and 14 had poorly differentiated tumor while in YOCR out of 66 patients, 15 had mucinous, and nine had poorly differentiated tumors. The difference was not significant (P = 0.39). The median CEA level in YOCR (6.06 ng/ml) was similar to that in the elder age group (4.75 ng/ml).
In YOCR, 75% patients were either in stage three or stage four disease compared to 62% patients in the older group as shown in [Table 3]. Metastasis was detected in 20 out of the 66 in the young group, whereas in the older group 18 out of 100 patients had metastatic disease (P = 0.08). The site of metastatic disease in older group was peritoneal n = 10, liver n = 6, combined n = 1 and supraclavicular lymph node n = 1 and in YOCR was peritoneal n = 13, combined n = 3 liver n = 2 and lymph nodal n = 2.
|Table 3: Stage-wise distribution of colorectal cancers among various subgroups|
Click here to view
The surgical treatment received by these patients is listed in [Table 4]. In the YOCR group among 19 patients with right sided tumor 14 (82%) underwent resection while four had bypass, and one patient received palliative chemotherapy. Of 47 left sided tumors, only 26 (55%) underwent resection while 15 patients had laparotomy and colostomy/ileostomy, and five patients were managed without surgical intervention. In the older group among 35 patients with right sided tumors, 30 (86%) underwent resection, three patients had bypass and ileostomy was done in remaining two patients. Among 65 left sided tumors 49 (75%) underwent resection while three patients had bypass, seven had colostomy and remaining seven were not offered surgical treatment. The resectability rate was not statistically significant among the right sided cancers when compared between two groups (YOCR74%vs. Older 86% P = 0.29). However there was a significant difference in resectability rate among the left sided tumors between YOCR group (55%) versus older group (75%) (P = 0.04). In the subgroup analysis of left sided tumors, 29 out of 39 patients with rectal or rectosigmoid tumors were resectable in the older group compared to only 18 out of 39 patients in YOCR group (P = 0.02).
Among 18 patients in YOCR with locally advanced (n = 6) and metastatic (n = 12) disease who received anterior chemoradiotherapy only four patients underwent resection. There was a partial response in two patients and stable disease in other two.
The overall survival of patients in YOCR group was 38% while in the older group was 36% at 48 months (P = 0.41). In stage wise analysis, overall survival of patients in stage II was 60% in YOCR group and 70% in the older group at 36 months (P = 0.33). The overall survival of patients in stage III was 39% in YOCR group and 29% in the older group at 48 months (P = 0.46). None of the patients in stage IV survived at 24 months in YOCR group and at 18 months in older group(P = 0.14). The stage wise comparison of survival of YOCR with the older group is shown in [Figure 1].
|Figure 1: The stage-wise comparison of Kaplan–Meier survival curves of young onset colorectal cancer with the older group|
Click here to view
| » Discussion|| |
In our experience increasing number of colorectal malignancies are being seen in the younger age group. There are variable reports in the literature as regards the incidence of colorectal cancer in the young. A population based study  concluded that it was 3%. However, reports from single center studies vary from 0.4% to 35%.,, In our center this incidence was 41% even after taking 40 years as cut off. Although, there could be some referral bias of the tertiary center but this incidence is definitely high in the patients in the younger group.
The distribution of these tumors among females increases in the YOCR group. The male female ratio decreases from 4:1 in the older group to 1.5:1 in the younger group.
There are conflicting reports in the literature about the most common site of colorectal cancer in young adults. Some studies say that right sided are more common , where as others suggest that the left sided are more common., However, in most studies the hereditary syndromes and ulcerative colitis related cancers were not excluded ,,,, therefore it does not reflect the true status of sporadic YOCR. It is important to exclude patients with predisposing conditions as screening in these patients can help in early detection that may change the outcome. We have excluded all hereditary syndromes and ulcerative colitis in order to address the true presentation of sporadic YOCR. We found YOCR patients to have a predilection to left sided tumors. Among left sided tumors, most of them were located in the rectum or rectosigmoid area. We also noticed that the younger the age group more was the incidence of left sided tumors. In 30–40 age group there were 15/41 right sided tumors, this reduced to 4/17 in the 20–30 age group which further reduced to 0/8 in up to 20 years.
According to O'Connell et al., an average of 22.7% of YOCR patients had family history of colorectal cancer. Mahdavinia et al. reported that the distribution of tumor site differed significantly between those with family history of colorectal cancer and those without this history. The authors evaluated 112 patients <45 years and found that individuals with a family history of colorectal cancer often had tumors localized to the proximal colon, but 77% of patients without a family history of colorectal cancer had tumors of the distal colorectum. In our study, we have found a similar left sided predominance (71%) in the younger age group. None of these patients had positive family history.
We found that the sporadic colorectal carcinomas of the younger age group were significantly more advanced at time of presentation. For young patients who develop colorectal cancer, but have no known predisposing genetic risk factors, late diagnosis and poor outcomes may result from the clinician's failure to consider the possibility of malignant disease in the differential diagnosis. However, in our series the median duration of symptoms before presentation was similar among both groups that is, 6 months. This suggests aggressive nature of the disease in YOCR group thereby resulting in advanced disease at time of presentation. Presence of incontinence and obstruction at time of presentation was significantly more common in YOCR group. This again shows sporadic YOCR are more advanced with a left sided predilection. In [Table 5] we have listed similar studies that have addressed sporadic young colorectal cancers and compared their attributes with ours. Minardi et al. found that 42% of the YOCR patients had mucinous differentiation while this pattern was less prevalent in the older population. O'Connell et al. suggested that this higher prevalence of mucinous/poorer differentiation is associated with the poorer prognosis and 5 year survival found in the younger group. However, hereditary syndromes were not excluded in the studies analyzed. Mucinous differentiation being a marker for microsatellite instability is found in hereditary colorectal cancer. Yantiss et al. reported a minority (13%) of patients with mucinous differentiation and attributed it to the fact that 92% of their patients did not have any genetic risk factors. They suggested that the inclusion of proximally located colonic cancers with underlying known genetic predisposition in such studies account for the reportedly high incidence of mucinous/poorer differentiation. Our results agree with this since there is no statistically significant difference in the incidence of mucinous/poorer differentiation in YOCR (36%) when compared to the older group (29%) having excluded all patients with family history of colorectal cancer.
|Table 5: Comparison of studies including sporadic young onset colorectal cancer|
Click here to view
Tumors in sporadic YOCR were less resectable compared to those in the older age group. This difference was significant for the left sided tumors (YOCR 26/47 vs. older 49/65 P = 0.04). Among right sided tumors, the resectability rate was not statistically different among YOCR (74%) and older patients (84%) P = 0.29. The incidence of metastatic disease was higher in YOCR group compared to the older (P = 0.08) group. In literature, few studies that have excluded hereditary syndromes have not analyzed and compared the resectability rates of the young colon cancers with the old. Among the other studies, the resectability rate for the young colon cancers ranged from 68% to 93%.,,,
In our study, there was no significant difference in the survival of young versus old patients. O'Connell et al. reported that the stage specific 5 year survival for young in Duke's A and B is better than the old in a literature review but a population based study found that the stage specific survival was better in the young in stage 1 and 4., Petrek et al. and Turkiewicz et al. have reported better overall survival in the young patients compared to the old., Minardi and Domergue, on the other hand, reported poorer overall 5 year survival especially in stage C and D young patients., It is important to note many of these studies have not excluded hereditary colorectal syndromes.
In large scale population based studies based on cancer registries, they have stated that the results have potential limitations and no information on any adjuvant therapy such as chemotherapy were available. In this study we attempted to overcome these limitations of previous studies. We studied the clinical, histological characteristics of YOCR with emphasis on the treatment they received, outcome and survival and then compared them with the older colorectal cancer patients.
One of the limitations of our study is that in this retrospective analysis we have excluded hereditary syndromes only by a detailed family history of the patient and not by genetic markers. There have been reports of a category of Microsatellite stable tumors among the sporadic early onset colorectal cancers where in the tumors are predominantly left sided and associated with fairly advanced disease., Hawkins et al. stated that diploid microsatellite stable tumors represent an aggressive subset of sporadic colorectal carcinomas. Mourra et al. suggested that the tumor suppressor gene located in chromosome 14 might have a role in microsatellite stable colon carcinogenesis and that it seems to be more frequently involved in early onset cases. However, Boardman et al. concluded in their study that first degree relatives of microsatellite stable colorectal cancer patients do have an increased risk for the development of GI tract cancer in general and of colorectal cancer in particular and that this variety may confer an increased familial risk for CRC that follows an autosomal recessive pattern of inheritance. It would be interesting to see if the left sided cases in the younger subgroups are linked to an unknown genetic etiology such as the microsatellite stable variety reported in the literature.
| » Conclusions|| |
Thus, our study indicates that the sporadic colorectal cancers of the young are predominantly left sided. They are more advanced and less resectable when compared to the elderly population. Genetic studies are needed to elaborate the reasons for left sided predominance and aggressiveness of these sporadic colorectal cancers in the younger subgroups.
| » References|| |
Griffin PM, Liff JM, Greenberg RS, Clark WS. Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study. Gastroenterology 1991;100:1033-40.
O'Connell JB, Maggard MA, Livingston EH, Yo CK. Colorectal cancer in the young. Am J Surg 2004;187:343-8.
Fairley TL, Cardinez CJ, Martin J, Alley L, Friedman C, Edwards B, et al.
Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer 2006;107:1153-61.
Minardi AJ Jr, Sittig KM, Zibari GB, McDonald JC. Colorectal cancer in the young patient. Am Surg 1998;64:849-53.
Domergue J, Ismail M, Astre C, Saint-Aubert B, Joyeux H, Solassol C, et al.
Colorectal carcinoma in patients younger than 40 years of age. Montpellier Cancer Institute experience with 78 patients. Cancer 1988;61:835-40.
Savas N, Dagli U, Akbulut S, Yuksel O, Sahin B. Colorectal cancer localization in young patients: Should we expand the screening program? Dig Dis Sci 2007;52:798-802.
Perea J, Alvaro E, Rodríguez Y, Gravalos C, Sánchez-Tomé E, Rivera B, et al.
Approach to early-onset colorectal cancer: Clinicopathological, familial, molecular and immunohistochemical characteristics. World J Gastroenterol 2010;16:3697-703.
O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Do young colon cancer patients have worse outcomes? World J Surg 2004;28:558-62.
Turkiewicz D, Miller B, Schache D, Cohen J, Theile D. Young patients with colorectal cancer: How do they fare? ANZ J Surg 2001;71:707-10.
Petrek JA, Sandberg WA, Bean PK. The role of gender and other factors in the prognosis of young patients with colorectal cancer. Cancer 1985;56:952-5.
Endreseth BH, Romundstad P, Myrvold HE, Hestvik UE, Bjerkeset T, Wibe A, et al.
Rectal cancer in the young patient. Dis Colon Rectum 2006;49:993-1001.
O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Rates of colon and rectal cancers are increasing in young adults. Am Surg 2003;69:866-72.
You YN, Xing Y, Feig BW, Chang GJ, Cormier JN. Young-onset colorectal cancer: Is it time to pay attention? Arch Intern Med 2012;172:287-9.
Edge SB, Byrd DR, Compton CC. In: American Joint Committee on Cancer, AJCC Cancer Staging Manual. 7th
ed. New York: Springer; 2010. p. 113-23.
Soliman AS, Bondy ML, Levin B, Hamza MR, Ismail K, Ismail S, et al.
Colorectal cancer in Egyptian patients under 40 years of age. Int J Cancer 1997;71:26-30.
Dozois EJ, Boardman LA, Suwanthanma W, Limburg PJ, Cima RR, Bakken JL, et al.
Young-onset colorectal cancer in patients with no known genetic predisposition: Can we increase early recognition and improve outcome? Medicine (Baltimore) 2008;87:259-63.
Mahdavinia M, Bishehsari F, Ansari R, Norouzbeigi N, Khaleghinejad A, Hormazdi M, et al.
Family history of colorectal cancer in Iran. BMC Cancer 2005;5:112.
Yantiss RK, Goodarzi M, Zhou XK, Rennert H, Pirog EC, Banner BF, et al.
Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 2009;33:572-82.
Hawkins NJ, Tomlinson I, Meagher A, Ward RL. Microsatellite-stable diploid carcinoma: A biologically distinct and aggressive subset of sporadic colorectal cancer. Br J Cancer 2001;84:232-6.
Mourra N, Zeitoun G, Buecher B, Finetti P, Lagarde A, Adelaide J, et al.
High frequency of chromosome 14 deletion in early-onset colon cancer. Dis Colon Rectum 2007;50:1881-6.
Boardman LA, Morlan BW, Rabe KG, Petersen GM, Lindor NM, Nigon SK, et al.
Colorectal cancer risks in relatives of young-onset cases: Is risk the same across all first-degree relatives? Clin Gastroenterol Hepatol 2007;5:1195-8.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5]
|This article has been cited by|
||Early onset sporadic colorectal cancer: Worrisome trends and oncogenic features
| ||Giulia Martina Cavestro,Alessandro Mannucci,Raffaella Alessia Zuppardo,Milena Di Leo,Elena Stoffel,Giovanni Tonon |
| ||Digestive and Liver Disease. 2018; 50(6): 521 |
|[Pubmed] | [DOI]|
||New trend in colorectal cancer in Germany: are young patients at increased risk for advanced colorectal cancer?
| ||Peter C. Ambe,Stefan Jansen,Hubert Zirngibl |
| ||World Journal of Surgical Oncology. 2017; 15(1) |
|[Pubmed] | [DOI]|